[1] | Haldane J. B. S. 1949 Disease and evolution. Ric. Sci. Suppl. A. 19, 68–76. |
[2] | Allison A. C. 1954 Protection afforded by sickle-cell trait against subtertian malarial infection. BMJ 1, 290–294. doi:10.1136/bmj.1.4857.290. |
[3] | Sabeti P. C., et al. 2006 Positive natural selection in the human lineage. Science 312, 1614–1620. doi:10.1126/ science.1124309. |
[4] | Sabeti P. C., et al. 2002 Detecting recent positive selection in the human genome from haplotype structure. Nature 419, 832–837. doi:10.1038/nature01140. |
[5] | The International HapMap Consortium. 2003 The International HapMap Project. Nature 426, 789–796. doi:10.1038/nature02168. |
[6] | Durbin R. M., Abecasis G. R., Altshuler D. L., Auton A., Brooks L. D., Durbin R. M., Gibbs R. A., Hurles M. E., McVean G. A.2010 A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073. doi:10.1038/nature09534. |
[7] | Nielsen R.2005 Molecular signatures of natural selection. Annu. Rev. Genet. 39, 197–218. doi:10.1146/annurev.genet. 39.073003.112420). |
[8] | Pollard K. S., et al. 2006 Forces shaping the fastest evolving regions in the human genome. PLoS Genet. 2, e168. doi:10.1371/journal.pgen.0020168. |
[9] | Voight B. F., Kudaravalli S., Wen X., Pritchard J. K.2006 A map of recent positive selection in the human genome. PLoS Biol. 4, e72. doi:10.1371/journal.pbio.0040072. |
[10] | Sabeti P. C., et al. 2007 Genome-wide detection and characterization of positive selection in human populations. Nature 449, 913–918. doi:10.1038/nature06250. |
[11] | Grossman S. R., et al. 2010 A composite of multiple signals distinguishes causal variants in regions of positive selection. Science 327, 883–886. doi:10.1126/science.1183863. |
[12] | Kunz S., Rojek J. M., Kanagawa M., Spiropoulou C. F., Barresi R., Campbell K. P. Oldstone M. B.2005 Posttranslational modification of α-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J. Virol. 79, 14 282–14 296. doi:10.1128/JVI.79.22.14282–14296.2005. |
[13] | McCormick J. B., Fisher-Hoch S. P. 2002 Lassa fever. Curr. Top. Microbiol. Immunol. 262, 75–109. doi:10.1007/978-3- 642-56029-3_4. |
[14] | McCormick J. B., King I. J., Webb P. A., Johnson K. M., O'Sullivan R., Smith E. S., Trippel S., Tong T. C.1987 A case–control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155, 445–455. doi:10.1093/ infdis/155.3.445. |
[15] | Troup J. M., White H. A., Fom A. L., Carey D. E. 1970 An outbreak of Lassa fever on the Jos plateau, Nigeria, in January-February 1970. A preliminary report. Am. J. Trop. Med. Hyg. 19, 695–696. |
[16] | Saitou N., Nei M. 1987 The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4, 406–425. |
[17] | Richmond J. K., Baglole D. J. 2003 Lassa fever: epidemiology, clinical features, and social consequences. BMJ 327, 1271–1275. doi:10.1136/bmj.327.7426.1271. |
[18] | Ehichioya D. U., et al.2011 Current molecular epidemiology of Lassa virus in Nigeria. J. Clin. Microbiol. 49, 1157–1161. doi:10.1128/JCM.01891–10. |
[19] | Bowen M. D., Rollin P. E., Ksiazek T. G., Hustad H. L., Bausch D. G., Demby A. H., Bajani M. D., Peters C. J., Nichol S. T.2000 Genetic diversity among Lassa virus strains. J. Virol. 74, 6992–7004. doi:10.1128/JVI.74.15.6992-7004. 2000. |
[20] | Ter Meulen J., et al. 1996 Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am. J. Trop. Med. Hyg. 55, 661–666. |
[21] | Wolfe N. D., Dunavan C. P., Diamond J. 2007 Origins of major human infectious diseases. Nature 447, 279–283. doi:10.1038/nature05775. |
[22] | Price M. E., Fisher-Hoch S. P., Craven R. B., McCormick J. B.1988 A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ 297, 584–587. doi:10.1136/bmj.297.6648.584. |
[23] | Kunz S. 2009 Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus–host interaction. Virology 387, 245–249. doi:10.1016/j.virol.2009.02.042. |
[24] | Yi J. S., Cox M. A., Zajac A. J. 2010 Interleukin-21: a multifunctional regulator of immunity to infections. Microbes Infect. 12, 1111–1119. doi:10.1016/j.micinf.2010.08.008. |
[25] | Elsaesser H., Sauer K., Brooks D. G. 2009 IL-21 is required to control chronic viral infection. Science 324, 1569–1572. doi:10.1126/science.1174182. |
[26] | Yi J. S., Du M., Zajac A. J. 2009 A vital role for interleukin-21 in the control of a chronic viral infection. Science 324, 1572–1576. doi:10.1126/science.1175194. |
[27] | Frohlich A., Kisielow J., Schmitz I., Freigang S., Shamshiev A. T., Weber J., Marsland B. J., Oxenius A., Kopf M.2009 IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324, 1576–1580. doi:10.1126/science.1172815. |
[28] | Oldstone M. B., Campbell K. P. 2011 Decoding arenavirus pathogenesis: essential roles for α-dystroglycan–virus interactions and the immune response. Virology 411, 170–179. doi:10.1016/j.virol.2010.11.023. |
[29] | Fry B. 2004 Computational information design. PhD thesis, Massachusetts Institute of Technology, Cambridge, MA. The Welcome Trust Case–Control Consortium 2007 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678. doi:10.1038/nature05911. |